SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Aklillu Eleni)
 

Sökning: WFRF:(Aklillu Eleni) > Monoamine metabolit...

Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.

Kishida, Ikuko (författare)
Aklillu, Eleni (författare)
Karolinska Institutet
Kawanishi, Chiaki (författare)
visa fler...
Bertilsson, Leif (författare)
Karolinska Institutet
Ågren, Hans, 1945 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
visa färre...
 (creator_code:org_t)
2007-02-14
2007
Engelska.
Ingår i: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. - : Springer Science and Business Media LLC. - 0893-133X. ; 32:10, s. 2143-51
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The serotonin (5-hydroxytryptamine) transporter (5-HTT) is considered to affect the pathogenesis of mood disorders. Large number of genetic association studies between 5-HTT functional polymorphisms and vulnerability of mood disorders and therapeutic response to antidepressants has been carried out. We investigated the influence of 5-HTT-linked polymorphic region (5-HTTLPR) and 5-HTT 17 bp variable number of tandem repeat polymorphism (5-HTTVNTR) polymorphisms on concentrations of monoamine metabolites in cerebrospinal fluid (CSF) among treatment-resistant patients with mood disorders. Subjects were 119 Swedish patients with persistent mood disorders and 141 healthy subjects. In 112 of these patients, we measured 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol in CSF. Genotyping for 5-HTT polymorphisms from genomic DNA was carried out by PCR. There was no significant difference in allele/genotype frequency between patients and healthy subjects. In patients with mood disorders, we found significant difference in mean 5-HIAA concentration between 5-HTTLPR genotypes (p=0.03). Although the 5-HIAA concentration showed a tendency to be higher in short (S) carriers than in non-S carriers of the 5-HTTLPR in patients (p=0.06), when considering patients with major depressive disorder (MDD), the 5-HIAA concentration was significantly higher among S carriers than among non-S carriers (p=0.02). Moreover, the 5-HIAA concentration was higher in S/S subjects compared to long (L)/L (p=0.0001) and L/S (p=0.002) subjects in patients with MDD. Similarly, there was higher HVA concentration in S/S subjects compared to L/L (p=0.002) and L/S subjects (p=0.002). There was no effect of 5-HTTVNTR. Our findings show that the 5-HTTLPR polymorphism affects 5-HIAA and HVA concentrations among treatment-resistant patients with mood disorders.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Psykiatri (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Psychiatry (hsv//eng)

Nyckelord

Adult
Aged
Biogenic Monoamines
cerebrospinal fluid
Brain Chemistry
genetics
DNA Mutational Analysis
Depressive Disorder
cerebrospinal fluid
genetics
physiopathology
Drug Resistance
genetics
Female
Genetic Predisposition to Disease
genetics
Genetic Screening
Genotype
Homovanillic Acid
cerebrospinal fluid
Humans
Hydroxyindoleacetic Acid
cerebrospinal fluid
Male
Methoxyhydroxyphenylglycol
analogs & derivatives
cerebrospinal fluid
Middle Aged
Mutation
genetics
Polymorphism
Genetic
genetics
Serotonin Plasma Membrane Transport Proteins
genetics
Tandem Repeat Sequences
genetics
Up-Regulation
physiology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy